Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 3, 1998, Pages 291-301

  Zhu, Jie ^a   Deng, Guo Min ^a   Levi, Michael ^b   Wahren, Britta ^b   Diab, Asim ^a   Van Der Meide, Peter H ^c   Link, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

Autoimmunity; ELISPOT; Experimental autoimmune neuritis; Guillain Barre syndrome; Mucosal tolerance; Nasal.

Indexed keywords

CD4 ANTIGEN; CYTOKINE; FREUND ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MYELIN; MYELIN BASIC PROTEIN; MYELIN BASIC PROTEIN[57-81]; PHYTOHEMAGGLUTININ; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CLONAL ANERGY; CONTROLLED STUDY; DEMYELINATING DISEASE; DOSE RESPONSE; GUILLAIN BARRE SYNDROME; HISTOPATHOLOGY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; INTRANASAL DRUG ADMINISTRATION; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MALE; NEURITIS; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

EID: 0031915666     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199803000-00010     Document Type: Article

References (34)

1. Waksman BH, Adams RD. Allergic neuritis: An experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvant. J Exp Med 1955;102:213-25
2. Kadlubowski M, Hughes RAC. Identification of the neuritogen for experimental allergic neuritis. Nature 1979;277:140-41
3. Milner PA, Lovelidge CA, Taylor WA, Hughes RAC. P0 myelin protein produces experimental allergic neuritis in Lewis rats. J Neurol Sci 1987;79:275-85
4. Olee T, Powers JM, Brostoff SW. A T cell epitope for experimental allergic neuritis. J Neuroimmunol 1988;19:167-73
5. Olee T, Powell HC, Brostoff SW. New minimum length requirement for a T cell epitope for experimental allergic neuritis. J Neuroimmunol 1990;27:187-90
6. Saida T, Saida K, Dorfman SH, Silberberg DH, Sumner AJ, Manning MC, Lisa RP, Brown MJ. Experimental allergic neuritis induced by sensitization with galactocerebroside. Science 1979;204: 1103-6
7. Linington C, Izumo S, Suzuki M, Uyemura K, Meyermann R, Wekerle H. A permanent rat cell line that mediates experimental allergic neuritis in the Lewis rats in vivo. J Immunol 1984;133:1946-50
8. Linington C, Lassmann H, Ozawa K, Kosin S, Mongan L. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. Eur J Immunol 1992; 22:1813-17
9. Hartung HP, Willison H, Jung S, Pette M, Toyka KV, Giegerich G. Autoimmune response in peripheral nerve. Springer Semin Immunopathol 1996;18:97-123
10. Hartung HP, Toyka KV. T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndrome. Ann Neurol 1990;27 (Suppl):S57-S63
11. Zhu J, Link H, Mix E, Olsson T, Huang W-X. Th1-like cell responses to peripheral nerve myelin components over the course of experimental allergic neuritis in Lewis rats. Acta Neurol Scand 1994;90:19-25
12. Zhu J, Link H, Weerth S, Linington C, Mix E, Qiao, J. The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1. J Neurol Sci 1994;125:132-37
13. Thompson HS, Staines NA. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 1986;64:581-86
14. Wang ZY, Qiao J, Link H. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J Neuroimmunol 1993;44:209-14
15. Thompson HS and Staines NA. Could specific oral tolerance be a therapy for autoimmune disease? Immunol Today 1990;11:396-99
16. Ma CG, Zhang GX, Xiao BG, Link J, Olsson T, Link H. Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor. J Neuroimmunol 1995;58: 51-60
17. Wraith DC. Antigen-specific immunotherapy of autoimmune disease: A commentary. Clin Exp Immunol 1996;103:349-52
18. Metzler B, Wraith DC. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: Inhibition of MHC binding affinity. Int J Immunol 1993;5:1159-65
19. Norton WI, Poduslo SE. Myelination in rat nerve: Method of myelin isolation. J Neurochem 1973;21:749-57
20. Williams AF, Galfre G, Milstein C. Analysis of cell surface by enogeneic myeloma hybrid antibodies: Differentiation antigens of rat lymphocytes. Cell 1987;12:663-73
21. Brideau RJ, Carter PB, McMaster WR, Mason DW, Williams AF. Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur J Immunol 1980;10:609-15
22. Sedwick J, Brostoff S, Mason D. Experimental allergic encephalomyelitis in the absence of a classical delayed type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system. J Exp Med 1987;165:1058-75
23. McMaster WR, Williams AF. Identification of Ia glycoprotein in rat thymus and purification from rat spleen. Eur J Immunol 1979;9: 426-33
24. Lindström J, Einarson B, Tzartos S. Production and assay of antibodies to acetylcholine receptors. Methods Enzymol 1981;74:432-60
25. Zhu J, Mix E, Olsson T, Link H. Cellular mRNA expression of interferon-γ, interleukin 4 and transforming growth factor-β by rat mononuclear cells stimulated with peripheral nerve antigens in experimental allergic neuritis. Clin Exp Immunol 1994;98:306-12
26. Metzler B, Wraith DC. Mucosal tolerance in a murine model of experimental autoimmune encepgalomyelitis. Ann NY Acad Sci 1996;778:228-43
27. Dick AD, Cheng YF, McKinnon A, Liverside J, Forrester JV. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Br J Ophthalmol 1993;77:171-75
28. Garside P, Steel M, Worthey EA, et al. T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J Immunol 1995;154:5649-55
29. Mondino A, Khoruts A, Jekins MK. The anatomy T-cell activation and tolerance. Proc Natl Acad Sci USA 1996;93:2245-52
30. Dijkema R, van der Meide HP, Dubbeld M, Wubben J, Schellekens H. Cloning expression and purification of rat IFN-γ. Methods Enzymol 1986;119:453-63
31. Shirai T, Shimizu N, Horiguchi S, Jto H. Rat TNF alpha. Agric Biol Chem 1989;53:1733-36
32. McKnight AJ, Barclay AN, Mason DW. Molecular cloning of rat intreleukin 4 cDNA and analysis of the cytokine repertoire of subsets of CD4+ T cells. Eur J Immunol 1991;21:1187-94
33. Moore KW, Vieia P, Fiorentino DF, Trounsteine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990;248: 1230-34
34. Derynck R, Jarett JA, Chen EY, et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1986;316:701-5